written on 03.04.2014

Mass vaccination 'more cost-effective than targeted campaigns' during flu epidemics

TAGS: ,

An EU-funded project to help governments develop cost-effective plans for responding to flu epidemics has come up with guidelines that make for interesting reading for all stakeholders, including the pharmaceutical industry.